Pediatric Infection and Vaccine

The Korean Society of Pediatric Infectious Diseases (대한소아감염학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Interferon-gamma Release Assay in Children with Confirmed Tuberculosis

확진된 소아청소년 결핵에서 인터페론감마 분비검사의 진단적 가치

  • Kim, Kyu Ho (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Kang, Ji-Man (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) ;
  • Ahn, Jong Gyun (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine)
  • 김규호 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과) ;
  • 강지만 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과) ;
  • 안종균 (연세대학교 의과대학 소아과학교실, 세브란스 어린이병원 소아청소년과)
  • Received : 2020.10.12
  • Accepted : 2021.04.19
  • Published : 2021.04.25
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: This study aimed to evaluate the diagnostic value of the QuantiFERON-TB Gold In-Tube (QFT-GIT) in children with confirmed tuberculosis (TB). Methods: We retrospectively reviewed the medical records of children aged ≤18 years who underwent both QFT-GIT and Mycobacterium tuberculosis culture between 2006 and 2017. Confirmed TB was defined as the presence of at least one positive specimen for M. tuberculosis on culture or a nucleic acid amplification test. Results: Of the 582 patients included in the analysis, 48 were confirmed to have TB. The sensitivity and specificity of QFT-GIT for the diagnosis of confirmed TB were 85.4% and 95.5%, respectively. Among children with confirmed TB, the proportion in the immunocompromised state was higher in the QFT-GIT negative group than in the QFT-GIT positive group (50.0% vs. 5.7%, P=0.010). The median age at sampling was lower in the QFT-GIT indeterminate group than in the QFT-GIT positive group (7 years vs. 17 years, P=0.008), and the proportion of immunosuppression was higher in the QFT-GIT indeterminate group than in the QFT-GIT positive group (42.9% vs. 5.7%, P=0.017). The interferon gamma response to mitogen control was significantly higher in the 10-18 years group than in the 0-9 years group (P<0.001), and was significantly higher in the immunocompetent group than in the immunocompromised group (P=0.001). Conclusion: The QFT-GIT results should be interpreted carefully in immunocompromised or younger children suspected of having TB.

목적: 이 연구의 목적은 소아청소년 결핵 질환의 진단에서 QuantiFERON-TB Gold In-Tube (QFT-GIT) 검사의 진단적 가치를 평가하는 것이다. 방법: 2006년부터 2017년까지 세브란스 병원에서 QFT-GIT 검사 및 결핵균 배양검사를 같이 시행했던 18세 이하 환아들의 의무기록을 후향적으로 확인하여 분석하였다. 결핵 확진은 결핵균 배양검사 또는 결핵균 핵산증폭검사에서 양성인 경우로 정의하였다. 결과: 분석 대상에 포함된 총 582명 중 결핵 확진 환아는 48명이었고, 결핵 미확진 환아는 534명이었다. 미정 결과를 제외하고 계산된 소아청소년 결핵 질환 진단에서 QFT-GIT 검사의 민감도와 특이도는 각각 85.4%와 95.5%이었다. 결핵 확진 환아들 중 QFT-GIT 음성군은 양성군보다 면역억제 상태의 환자가 더 많았으며(50.0% vs. 5.7%, P=0.010), QFT-GIT 미정군은 양성군보다 나이의 중앙값이 낮고(7세 vs. 17세, P=0.008), 면역억제 상태의 환자가 더 많았다(42.9% vs. 5.7%, P=0.017). 10-18세군은 0-9세군보다 양성 대조군인 mitogen에 대한 인터페론감마 분비 농도가 높았고(P<0.001), 면역정상군은 면역억제군보다 mitogen에 대한 인터페론감마 분비 농도가 높았다(P=0.001). 결론: QFT-GIT 검사 결과는 면역억제 환아나 어린 나이의 소아에서 활동성 결핵이 의심되는 경우 주의 깊게 해석되어야 한다.

Keywords

References

  1. Annabel B, Anna D, Hannah M. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.
  2. Marais BJ, Graham SM, Maeurer M, Zumla A. Progress and challenges in childhood tuberculosis. Lancet Infect Dis 2013;13:287-9. https://doi.org/10.1016/S1473-3099(13)70031-8
  3. Lamb GS, Starke JR. Tuberculosis in infants and children. Microbiol Spectr 2017;5.
  4. National Collaborating Centre for Chronic Conditions (UK); Centre for Clinical Practice at NICE (UK). Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians; 2011.
  5. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
  6. Auguste P, Tsertsvadze A, Pink J, Court R, McCarthy N, Sutcliffe P, et al. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis. BMC Infect Dis 2017;17:200. https://doi.org/10.1186/s12879-017-2301-4
  7. Kang WL, Wang GR, Wu MY, Yang KY, Er-Tai A, Wu SC, et al. Interferon-gamma release assay is not appropriate for the diagnosis of active tuberculosis in high-burden tuberculosis settings: a retrospective multicenter investigation. Chin Med J (Engl) 2018;131:268-75. https://doi.org/10.4103/0366-6999.223860
  8. Sester M, Sotgiu G, Lange C, Giehl C, Girardi E, Migliori GB, et al. Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37:100-11. https://doi.org/10.1183/09031936.00114810
  9. Chiappini E, Accetta G, Bonsignori F, Boddi V, Galli L, Biggeri A, et al. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a systematic review and meta-analysis. Int J Immunopathol Pharmacol 2012;25:557-64. https://doi.org/10.1177/039463201202500301
  10. Lombardi G, Pellegrino MT, Denicolo A, Corsini I, Tadolini M, Bergamini BM, et al. QuantiFERON-TB performs better in children, including infants, than in adults with active tuberculosis: a multicenter study. J Clin Microbiol 2019;57:e01048-19.
  11. Fan L, Chen Z, Hao XH, Hu ZY, Xiao HP. Interferon-gamma release assays for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. FEMS Immunol Med Microbiol 2012;65:456-66. https://doi.org/10.1111/j.1574-695X.2012.00972.x
  12. Cho OH, Park KH, Kim SM, Park SJ, Moon SM, Chong YP, et al. Diagnostic performance of T-SPOT.TB for extrapulmonary tuberculosis according to the site of infection. J Infect 2011;63:362-9. https://doi.org/10.1016/j.jinf.2011.06.010
  13. Pourakbari B, Mamishi S, Benvari S, Mahmoudi S. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube interferon-γ release assays: a systematic review and meta-analysis. Adv Med Sci 2019;64:437-43. https://doi.org/10.1016/j.advms.2019.09.001
  14. Kim EY, Park MS, Kim YS, Kim SK, Chang J, Kang YA. Risk factors for false-negative results of QuantiFERON-TB Gold In-Tube assay in non-HIV-infected patients with culture-confirmed tuberculosis. Diagn Microbiol Infect Dis 2011;70:324-9. https://doi.org/10.1016/j.diagmicrobio.2011.02.011
  15. Tebruegge M, de Graaf H, Sukhtankar P, Elkington P, Marshall B, Schuster H, et al. Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results. J Clin Microbiol 2014;52:2694-7. https://doi.org/10.1128/JCM.00814-14
  16. Haustein T, Ridout DA, Hartley JC, Thaker U, Shingadia D, Klein NJ, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J 2009;28:669-73. https://doi.org/10.1097/INF.0b013e3181a16394
  17. Connell TG, Tebruegge M, Ritz N, Bryant PA, Leslie D, Curtis N. Indeterminate interferon-gamma release assay results in children. Pediatr Infect Dis J 2010;29:285-6. https://doi.org/10.1097/INF.0b013e3181c4822f
  18. Lewinsohn DA, Lobato MN, Jereb JA. Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr 2010;22:71-6. https://doi.org/10.1097/MOP.0b013e3283350301
  19. Starke JR; Committee on Infectious Diseases. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics 2014;134:e1763-73. https://doi.org/10.1542/peds.2014-2983
  20. American Academy of Pediatrics. Tuberculosis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2018 report of the Committee on Infectious Diseases. 31st ed. Itasca: American Academy of Pediatrics, 2018:829-53.
  21. Ahmed A, Feng PI, Gaensbauer JT, Reves RR, Khurana R, Salcedo K, et al. Interferon-γ release assays in children <15 years of age. Pediatrics 2020;145:e20191930. https://doi.org/10.1542/peds.2019-1930
  22. Wendorf KA, Lowenthal P, Feraud J, Cabanting N, Murto C. Interferon-γ release assays for tuberculosis infection diagnosis in refugees <5 years old. Pediatrics 2020;146:e20200715. https://doi.org/10.1542/peds.2020-0715